Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia

被引:0
作者
Takuya Maeda
Azusa Hiura
Jiro Uehara
Rino Toyoshima
Tomoe Nakagawa
Koji Yoshino
机构
[1] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Dermatologic Oncology
来源
European Journal of Dermatology | 2021年 / 31卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:662 / 664
页数:2
相关论文
共 50 条
[21]   HEALTH CARE COST COMPARISON ANALYSIS OF NIVOLUMAB plus IPILIMUMAB REGIMEN AND NIVOLUMAB MONOTHERAPY VERSUS ESTABLISHED ADVANCED MELANOMA THERAPIES UTILIZING CLINICAL TRIAL AND REAL-WORLD DATA [J].
Potluri, R. ;
Okoro, T. ;
Bhandari, H. ;
Sabater, J. ;
Ranjan, S. ;
Kotapati, S. .
VALUE IN HEALTH, 2016, 19 (03) :A144-A144
[22]   Real-world efficacy of nivolumab in Peruvian patients with advanced melanoma [J].
Roque, Katia ;
Valencia, Guillermo ;
Rioja, Patricia ;
Huaman Campos, Jose Andres ;
Colomo Costas, Valeria ;
Mantilla, Raul ;
Morante, Zaida ;
Fuentes, Hugo ;
Munante, Bruno ;
Vidaurre, Tatiana ;
Neciosup, Silvia P. ;
De Mello, Ramon Andrade B. ;
Leonidas Gomez, Henry ;
Castaneda Altamirano, Carlos Arturo .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[23]   Real-world outcomes in advanced melanoma patients treated with first-line nivolumab plus ipilimumab [J].
Kozak, Katarzyna ;
Teterycz, Pawel ;
Galus, Lukasz ;
Mackiewicz, Jacek ;
Galwas-Kliber, Katarzyna ;
Kaminska-Winciorek, Grazyna ;
Brandys, Piotr ;
Cybulska-Stopa, Bozena ;
Kempa-Kaminska, Natasza ;
Zietek, Marcin ;
Zubrowska, Justyna ;
Dziura, Robert ;
Dembinski, Mateusz ;
Bereza, Michal ;
Czarnecka, Anna Malgorzata ;
Rutkowski, Piotr .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[24]   Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma [J].
Weber, J. ;
Mandala, M. ;
Del Vecchio, M. ;
Gogas, H. J. ;
Arance, A. M. ;
Cowey, C. L. ;
Dalle, S. ;
Schenker, M. ;
Chiarion-Sileni, V. ;
Marquez-Rodas, I. ;
Grob, J-J. ;
Butler, M. O. ;
Middleton, M. R. ;
Maio, M. ;
Atkinson, V. ;
Queirolo, P. ;
Gonzalez, R. ;
Kudchadkar, R. R. ;
Smylie, M. ;
Meyer, N. ;
Mortier, L. ;
Atkins, M. B. ;
Long, G. V. ;
Bhatia, S. ;
Lebbe, C. ;
Rutkowski, P. ;
Yokota, K. ;
Yamazaki, N. ;
Kim, T. M. ;
de Pril, V. ;
Sabater, J. ;
Qureshi, A. ;
Larkin, J. ;
Ascierto, P. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19) :1824-1835
[25]   Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma [J].
Dumoulin, D. W. ;
Douma, L. H. ;
Hofman, M. M. ;
van der Noort, V. ;
Cornelissen, R. ;
de Gooijer, C. J. ;
Burgers, J. A. ;
Aerts, J. G. J. V. .
LUNG CANCER, 2024, 187
[26]   Real-world Data on advanced Melanoma: First Data from a national, prospective, non-interventional Study of Nivolumab in Combination with Ipilimumab or as Nivolumab Monotherapy (NICO) [J].
Weichenthal, M. ;
Gutzmer, R. ;
Eigentler, T. ;
Mohr, P. ;
Goeppner, D. ;
Haferkamp, S. ;
Herber, M. ;
Herbst, R. ;
Meier, F. ;
Meiss, F. ;
Pfoehler, C. ;
Schneider, S. W. ;
Terheyden, P. ;
Ulrich, J. ;
Utikal, J. ;
Weishaupt, C. ;
Welzel, J. ;
Schadendorf, D. .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 :5-6
[27]   Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915) [J].
Weber, Jeffrey S. ;
Schadendorf, Dirk ;
Del Vecchio, Michele ;
Larkin, James ;
Atkinson, Victoria ;
Schenker, Michael ;
Pigozzo, Jacopo ;
Gogas, Helen ;
Dalle, Stephane ;
Meyer, Nicolas ;
Ascierto, Paolo A. ;
Sandhu, Shahneen ;
Eigentler, Thomas ;
Gutzmer, Ralf ;
Hassel, Jessica C. ;
Robert, Caroline ;
Carlino, Matteo S. ;
Di Giacomo, Anna Maria ;
Butler, Marcus O. ;
Munoz-Couselo, Eva ;
Brown, Michael P. ;
Rutkowski, Piotr ;
Haydon, Andrew ;
Grob, Jean-Jacques ;
Schachter, Jacob ;
Queirolo, Paola ;
de la Cruz-Merino, Luis ;
Haydon, Andrew ;
Grob, Jean-Jacques ;
Schachter, Jacob ;
Queirolo, Paola ;
De La Cruz-Merino, Luis ;
van der Westhuizen, Andre ;
Menzies, Alexander M. ;
Re, Sandra ;
Bas, Tuba ;
de Pril, Veerle ;
Braverman, Julia ;
Tenney, Daniel J. ;
Tang, Hao ;
Long, Georgina, V .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) :517-+
[28]   Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma [J].
Wolchok, Jedd D. ;
Chiarion-Sileni, Vanna ;
Gonzalez, Rene ;
Grob, Jean-Jacques ;
Rutkowski, Piotr ;
Lao, Christopher D. ;
Cowey, C. Lance ;
Schadendorf, Dirk ;
Wagstaff, John ;
Dummer, Reinhard ;
Ferrucci, Pier Francesco ;
Smylie, Michael ;
Butler, Marcus O. ;
Hill, Andrew ;
Marquez-Rodas, Ivan ;
Haanen, John B. A. G. ;
Guidoboni, Massimo ;
Maio, Michele ;
Schoffski, Patrick ;
Carlino, Matteo S. ;
Lebbe, Celeste ;
McArthur, Grant ;
Ascierto, Paolo A. ;
Daniels, Gregory A. ;
Long, Georgina, V ;
Bas, Tuba ;
Ritchings, Corey ;
Larkin, James ;
Hodi, F. Stephen .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) :127-+
[29]   Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy [J].
Menzer, Christian ;
Beedgen, Bernd ;
Rom, Joachim ;
Duffert, Christin M. ;
Volckmar, Anna-Lena ;
Sedlaczek, Oliver ;
Richtig, Erika ;
Enk, Alexander ;
Jaeger, Dirk ;
Hassel, Jessica C. .
EUROPEAN JOURNAL OF CANCER, 2018, 104 :239-242
[30]   Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma [J].
Asher, Nethanel ;
Ben-Betzalel, Guy ;
Lev-Ari, Shaked ;
Shapira-Frommer, Ronnie ;
Steinberg-Silman, Yael ;
Gochman, Neta ;
Schachter, Jacob ;
Meirson, Tomer ;
Markel, Gal .
CANCERS, 2020, 12 (08) :1-18